UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Design and radiosynthesis of class-IIa HDAC inhibitor with high molar activity via repositioning the 18F-radiolabel

Scientific reports, 2024-07, Vol.14 (1), p.15100-8, Article 15100

2024

Volltextzugriff (PDF)

Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues

Annals of surgical oncology, 2018-09, Vol.25 (9), p.2767-2775

2018

Volltextzugriff (PDF)

Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging

International journal of molecular sciences, 2024-07, Vol.25 (13), p.6870

2024

Volltextzugriff (PDF)

Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

Blood, 2008-08, Vol.112 (4), p.1424-1433

2008

Volltextzugriff (PDF)

Inhibition of Heat Shock Protein 90 Function by 17-Allylamino-17-Demethoxy-Geldanamycin in Hodgkin's Lymphoma Cells Down-Regulates Akt Kinase, Dephosphorylates Extracellular Signal–Regulated Kinase, and Induces Cell Cycle Arrest and Cell Death

Clinical cancer research, 2006-01, Vol.12 (2), p.584-590

2006

Volltextzugriff (PDF)

Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL‐R1 and TRAIL‐R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin‐ and bortezomib‐induced cell death

British journal of haematology, 2005-08, Vol.130 (4), p.501-510

2005

Volltextzugriff (PDF)

The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells

Blood, 2008-08, Vol.112 (3), p.711-720

2008

Volltextzugriff (PDF)

Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors

Clinical cancer research, 2004-05, Vol.10 (9), p.3207-3215

2004

Volltextzugriff (PDF)

Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

British journal of cancer, 2019-01, Vol.120 (1), p.88-96

2019

Volltextzugriff (PDF)

A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease

Annals of surgical oncology, 2023-02, Vol.30 (2), p.804-813

2023

Volltextzugriff (PDF)

ASO Visual Abstract: A Multicenter, Phase 1, Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery in Patients with Peritoneal Surface Disease

Annals of surgical oncology, 2023-02, Vol.30 (2), p.814-815

2023

Volltextzugriff (PDF)

Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma

Experimental hematology, 2008-04, Vol.36 (4), p.443-450

2008

Volltextzugriff (PDF)

Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

British journal of cancer, 2020-08, Vol.123 (3), p.495-495

2020

Volltextzugriff (PDF)

The heat shock protein 90 inhibitor 17‐AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9

British journal of haematology, 2006-10, Vol.135 (1), p.68-71

2006

Volltextzugriff (PDF)

Case report of intestinal non-rotation, heterotaxy, and polysplenia in a patient with pancreatic cancer

Medicine (Baltimore), 2017-12, Vol.96 (49), p.e8599-e8599

2017

Volltextzugriff (PDF)

Prognostic significance of serum B-lymphocyte stimulator level in Hodgkin's lymphoma

Haematologica (Roma), 2007-02, Vol.92 (2), p.269-270

2007

Volltextzugriff (PDF)

Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma

British journal of haematology, 2006-02, Vol.132 (4), p.503-511

2006

Volltextzugriff (PDF)

From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy

Expert review of anticancer therapy, 2006-01, Vol.6 (1), p.131-140

2006

Volltextzugriff (PDF)

Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond

Future oncology (London, England), 2005-04, Vol.1 (2), p.273-281

2005

Volltextzugriff (PDF)

The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression

Experimental hematology, 2006-12, Vol.34 (12), p.1670-1679

2006

Volltextzugriff (PDF)

Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma

European journal of cancer (1990), 2006-03, Vol.42 (4), p.542-547

2006

Volltextzugriff (PDF)

Expression of heat-shock protein-90 in non-Hodgkin's lymphomas

Modern pathology, 2005-10, Vol.18 (10), p.1343-1349

2005

Volltextzugriff (PDF)

Further experience with pancreatic stump closure using a reinforced staple line

Connecticut medicine, 2013-04, Vol.77 (4), p.205

2013

Volltextzugriff (PDF)

Elevated serum BLyS levels in patients with non-Hodgkin lymphoma

Leukemia & lymphoma, 2007-09, Vol.48 (9), p.1869-1871

2007

Volltextzugriff (PDF)

P-153: Management of access port infection in patients with adjustable gastric banding

Surgery for obesity and related diseases, 2010, Vol.6 (3), p.S77-S77

2010

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Design and radiosynthesis of class-IIa HDAC inhibitor with high molar activity via repositioning the 18F-radiolabel

Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues

Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging

Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

Inhibition of Heat Shock Protein 90 Function by 17-Allylamino-17-Demethoxy-Geldanamycin in Hodgkin's Lymphoma Cells Down-Regulates Akt Kinase, Dephosphorylates Extracellular Signal–Regulated Kinase, and Induces Cell Cycle Arrest and Cell Death

Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL‐R1 and TRAIL‐R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin‐ and bortezomib‐induced cell death

The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells

Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors

Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease

ASO Visual Abstract: A Multicenter, Phase 1, Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery in Patients with Peritoneal Surface Disease

Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma

Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

The heat shock protein 90 inhibitor 17‐AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9

Case report of intestinal non-rotation, heterotaxy, and polysplenia in a patient with pancreatic cancer

Prognostic significance of serum B-lymphocyte stimulator level in Hodgkin's lymphoma

Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma

From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy

Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond

The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression

Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma

Expression of heat-shock protein-90 in non-Hodgkin's lymphomas

Further experience with pancreatic stump closure using a reinforced staple line

Elevated serum BLyS levels in patients with non-Hodgkin lymphoma

P-153: Management of access port infection in patients with adjustable gastric banding

Suchergebnisse filtern